Sebastian Siebelmann

Sebastian Siebelmann

Auto-generated profile, based on publicly available information

Sebastian Siebelmann

Department of Ophthalmology, University of Cologne, Cologne, Germany

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
SSSilvia Schrittenlocher
Silvia Schrittenlocher
FSFriederike Schaub
Friederike Schaub
DHDeniz Hos
Deniz Hos
SSSebastian Siebelmann
Sebastian Siebelmann
CCClaus Dr. Cursiefen
Claus Dr. Cursiefen
BBBjörn Bachmann
Björn Bachmann

1 May 2018 in Survey of Ophthalmology
Verified
Journal Article
Closed access
SSSebastian Siebelmann
Sebastian Siebelmann
PSPaula Scholz
Paula Scholz
SSSimon Sonnenschein
Simon Sonnenschein
BBBjörn Bachmann
Björn Bachmann
MMMario Matthaei
Mario Matthaei
LHLudwig M. Heindl
Ludwig M. Heindl

19 April 2018 in American Journal of Transplantation
Verified
Journal Article
Open access
PDF file
YHYanhong Hou
Yanhong Hou
VLViet Nhat Hung Le
Viet Nhat Hung Le
GTGábor Tóth
Gábor Tóth
SSSebastian Siebelmann
Sebastian Siebelmann
JHJens Horstmann
Jens Horstmann
CCClaus Dr. Cursiefen
Claus Dr. Cursiefen
Immunologic graft rejection is the main complication after corneal transplant into pathologically prevascularized so‐called high‐risk eyes. The aim of this study was to evaluate whether ultraviolet (UV) light crosslinking can regress pathologic corneal blood and lymphatic vessels and thereby improve subsequent graft survival. Using the murine model of suture‐induced corneal neovascularization, we found that corneal crosslinking with UVA light and riboflavin regressed both preexisting blood and lymphatic vessels significantly via induction of apoptosis in vascular endothelial cells. In addition, macrophages and CD45+ cell counts were significantly reduced. Consistently, corneal crosslinking reduced keratocyte density and corneal thickness without affecting corneal nonvascular endothelial cells, iris, and lens depending on the crosslinking duration. Furthermore, using the murine model of corneal transplant, long‐term graft survival was significantly promoted (P < .05) and CD4+CD25+FoxP3+ T regulatory cells were upregulated (P < .01) in high‐risk eyes preoperatively treated with crosslinking. Our results suggest UV light crosslinking as a novel method to regress both pathologic corneal blood and lymphatic vessels and to reduce CD45+ inflammatory cells. Furthermore, this study demonstrates for the first time that preoperative corneal crosslinking in prevascularized high‐risk eyes can significantly improve subsequent graft survival and may become a promising novel therapy in the clinic.

5 April 2018 in Cornea
Verified
Journal Article
Closed access
SSSebastian Siebelmann
Sebastian Siebelmann
SRSebastian Lopez Ramos
Sebastian Lopez Ramos
PSPaula Scholz
Paula Scholz
MMMario Matthaei
Mario Matthaei
SSSilvia Schrittenlocher
Silvia Schrittenlocher
CCClaus Cursiefen
Claus Cursiefen
Purpose: The change from air to 20% sulfur hexafluoride (SF6) as anterior chamber tamponade for Descemet membrane endothelial keratoplasty (DMEK) significantly reduced the rebubbling rate. Nonetheless, underlying mechanisms are not completely understood. In this study, we investigate the morphology of graft detachments after DMEK depending on the tamponade and its influence on postoperative rebubbling. Methods: In this retrospective analysis of prospective data of 204 consecutive patients who underwent DMEK with 100% air, or 20% SF6, we compared the SF6 group with the air group regarding the number, lateral and axial diameter and localization of detachments, visual acuity (BSCVA), and incidence of rebubbling after 1 week (T1), after 1 (T2), 3 (T3), 6 (T4), and 12 (T5) months postoperatively. Results: The air group showed more detachments at all time points. Detachments in this group were of a larger axial diameter at T1, T4, and T5 and of a larger lateral diameter at T1, T3, T4, and T5 compared with the SF6 group. Patients receiving SF6 needed fewer rebubblings at T1 compared with patients receiving air (12.1% vs. 29.1%, P = 0.003), but not at T2 (15.1% vs. 19.1%, P = 0.56). There was no difference in postoperative BSCVA between the groups. Conclusions: Early graft attachment after DMEK, which is improved by the use of SF6 as anterior chamber tamponade, is important for the overall rebubbling rate and improves wound-healing mechanisms between the graft and recipient cornea. Faster resolving air tamponade is associated with extended detachments especially inferiorly and mid-peripherally, but has no negative effect on the long-term BSCVA.

1 December 2015 in Ophthalmology
Verified
Journal Article
Closed access
SSSebastian Siebelmann
Sebastian Siebelmann
MHManuel Hermann
Manuel Hermann
TDThomas Dietlein
Thomas Dietlein
BBBjörn Bachmann
Björn Bachmann
PSPhilipp Steven
Philipp Steven
CCClaus Cursiefen
Claus Cursiefen

17 August 2020 in British Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
SSSebastian Siebelmann
Sebastian Siebelmann
KKKatharina Kolb
Katharina Kolb
PSPaula Scholz
Paula Scholz
MMMario Matthaei
Mario Matthaei
JFJeremy Franklin
Jeremy Franklin
CCClaus Cursiefen
Claus Cursiefen
Background/Aims: To analyse graft detachments prior to rebubbling, the influence of rebubbling on the postoperative outcome after Descemet membrane endothelial keratoplasty (DMEK) and the need for rebubbling on the contralateral eye.Methods: In this retrospective cohort study, out of 1541 DMEKs, optical coherence tomography scans and clinical records of 499 eyes undergoing rebubbling after DMEK at the University Hospital of Cologne, Cologne, Germany, were examined. Main Outcome measures were (a) number, localisation and size of graft detachments; (b) influence of rebubbling/s on postoperative outcome after 12 months; and (c) rebubbling risk of the contralateral eye after DMEK.Results: Mean number of detachment areas was 2.02±0.9. Mean lateral diameter of all detachments was 4534.76±1920.83 μm. Mean axial diameter was 382.53±282.02 μm. Detachments were equally distributed over all regions of the cornea. Best spectacle corrected visual acuity ( BSCVA) after 12 months was 0.197±0.23 logarithm of the minimum angle of resolution, endothelial cell density (ECD) was 1575.21±397.71 cells/mm2 and mean central corneal thickness (CCT) was 566.37±68.11 μm. BSCVA, CCT, ECD or endothelial cell loss of all rebubbled patients were not influenced by the number of rebubblings or the time between DMEK and rebubbling. Of the rebubbled patients, which received a DMEK subsequently on the other eye, 193 (58.8%) also received a rebubbling, which was significantly higher, when compared to the overall rebubbling rate of 32.3% (p=0.000).Conclusions: The overall number of rebubblings has no influence on the postoperative outcome after DMEK, if a rebubbling becomes necessary. Patients who received a rebubbling on one eye have an elevated risk for a rebubbling on the fellow eye.